Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Uridine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC28A1 | O00337 | 1/20 | 0.90 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.90 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.90 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.90 |
| ▸ | P2RY2 | P41231 | 11/20 | 0.74 |
| ▸ | P2RY6 | Q15077 | 8/20 | 0.69 |
| ▸ | P2RY4 | P51582 | 4/20 | 0.68 |
| ▸ | P2RY14 | Q15391 | 7/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine SCHEMBL30094506 | 1.00 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL29801499 | 1.00 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL28065954 | 1.00 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL376208 | 1.00 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL76681 | 1.00 | SLC28A1 (0.90) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL28131489 | 0.99 | SLC28A1 (0.88) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL17074124 | 0.99 | SLC28A1 (0.88) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL2370972 | 0.99 | SLC28A1 (0.88) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL17439380 | 0.95 | SLC28A1 (0.85) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 | |
| Uridine SCHEMBL5330850 | 0.95 | SLC28A1 (0.85) | SLC28A1SLC28A2SLC29A1SLC28A3P2RY2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 5422 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4401580-B1 | SOLID COMPOSITION SUITABLE AS A NUTRITIONAL COMPOSITION OR SUPPLEMENT FOR ANIMALS THAT SUFFER FROM BRAIN RELATED DISORDERS, DECLINE OR DISEASES | NUTRICIA NV (NL) | 2026-05-27 | — | — | EP | claimed |
| EP-4748443-A2 | SOLID COMPOSITION SUITABLE AS A NUTRITIONAL COMPOSITION OR SUPPLEMENT FOR ANIMALS THAT SUFFER FROM BRAIN RELATED DISORDERS, DECLINE OR DISEASES | N.V. Nutricia (NL) | 2026-05-27 | — | — | EP | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | claimed |
| US-20260098284-A1 | CELL-FREE PPi-DRIVEN ATP REGENERATION PLATFORM | TYMOSHENKO STEPAN (US) | 2026-04-09 | — | — | US | claimed |
| US-20260063623-A1 | METHODS OF ASSESSING METABOLIC FLUX | UNIV MICHIGAN REGENTS (US) | 2026-03-05 | — | — | US | claimed |
| US-20260034171-A1 | Composition for Improving Cognitive Function | PERRY STEPHEN C (US) | 2026-02-05 | — | — | US | claimed |
| US-12533371-B2 | Multilayer pharmaceutical or nutraceutical solid dosage forms comprising pyrimidine and/or purine derivatives and b vitamins, preparation and uses thereof | FERRER INTERNACIONAL, S.A. (ES) | 2026-01-27 | — | — | US | claimed |
| US-20250277216-A1 | Allele-Specific Silencing of Transforming Growth Factor Beta Induced Gene with R124H Mutation Using Short Interfering RNA | AVELLINO LAB USA, INC. (CA) | 2025-09-04 | — | — | US | claimed |
| EP-4602365-A2 | METHODS OF ASSESSING METABOLIC FLUX | The Regents of The University of Michigan (US) | 2025-08-20 | — | — | EP | claimed |
| WO-2000020045-A1 | DEVICE FOR TREATMENT OF BIOLOGICAL FLUIDS | COMMON SERVICES AGENCY (GB) | 2000-04-13 | — | — | WO | claimed |
| US-5866378-A | Process for the synthesis of nucleotide-6-deoxy-D-xylo-4-hexuloses | HOECHST AKTIENGESELLSCHAFT (DE) | 1999-02-02 | — | — | US | claimed |
| WO-1995016785-A1 | USE OF THERMOPHILIC BACTERIA TO MANUFACTURE TRIAZOLE NUCLEOSIDES | OPACIC GORDANA (YU) | 1995-06-22 | — | — | WO | claimed |
| EP-0538268-A4 | TARGETED PROTECTION FROM CYTOTOXINS | — | 1993-05-12 | — | — | EP | claimed |
| EP-0538268-A1 | TARGETED PROTECTION FROM CYTOTOXINS | THE UNIVERSITY OF CONNECTICUT (US) | 1993-04-28 | — | — | EP | claimed |
| EP-0484266-A2 | Fat mixture for infant and adult nutrition | PULEVA UNION INDUSTRIAL Y AGRO-GANADERA, S.A. (ES) | 1992-05-06 | — | — | EP | claimed |
| WO-1991017761-A1 | TARGETED PROTECTION FROM CYTOTOXINS | THE UNIVERSITY OF CONNECTICUT (US) | 1991-11-28 | — | — | WO | claimed |
| CN-1056530-A | Saccharides and synthetic method thereof and equipment | UNIV PENNSYLVANIA (US) | 1991-11-27 | — | — | CN | claimed |
| US-5009994-A | Uniform distribution | EM DIAGNOSTIC SYSTEMS, INC. (US) | 1991-04-23 | — | — | US | claimed |
| EP-0343783-A2 | Method for producing cells containing stably integrated foreign DNA at a high copy number, the cells produced by this method, and the use of these cells to produce the polypeptides coded for by the foreign DNA | BTG USA INC (US) | 1989-11-29 | — | — | EP | claimed |